Mr. Neil Barber

Mr. Neil Barber
Having been appointed as a Consultant Urological Surgeon to Frimley Park Hospital in 2005, Neil Barber is Clinical Lead for Urology at Frimley Health NHS Foundation Trust and Director of the Frimley Renal Cancer Centre and the Frimley Benign Prostate Clinical Research Centre. Neil’s experience allows him to provide the full breadth of Urological care, including issues ranging from prostate cancer and prostate cancer diagnostics, to urinary tract infections, prostatitis, kidney conditions and cancer, peno-scrotal conditions and fertility, offering both vasectomy and vasectomy reversal. His particular subspecialist interests in managing waterworks symptoms in women and men, particularly for men suffering with BPH, has led to his involvement in new cutting edge treatments including the introduction to NHS England of the Greenlight laser in 2002 and Urolift in 2014. Most recently, Neil has been at the forefront of bringing a new technique for treating BPH using water jet ablation –Aquablation. The WATER study was set up and this global prospective double blind study compared Aquablation therapy to TURP. Neil is the leading surgeon in the UK to be trialling this procedure through the NHS at Frimley Park Hospital. As part of the journey of “Aquablation”, Neil has been presenting at conferences globally and also welcoming visiting surgeons to see the procedure in action. Neil has been involved in numerous high quality national, European and global studies in this field and is recognized as a Key Opinion Leader and clinical advisor both to industry and to NICE. His aim is to offer men suffering with bothersome waterworks symptoms as a result of BPH, the full range of treatment options and tailoring the best surgical approach to both the patients’ goals, the severity of the condition and the anatomy of that patients’ prostate. Beyond that Neil has developed a specialist team in the delivery of surgical solutions for kidney disorders, primarily involving renal cancer but also other conditions of the upper urinary tract including PUJ obstruction. Neil has been performing advanced and complex robotic assisted surgery in this field for over 10 years, the Frimley Renal Cancer Centre (FRCC) performing the highest number of robotic assisted partial nephrectomy for renal tumours per year in the UK year on year. Whilst building this service around the Intuitive Surgical robotic platform, Da Vinci, Neil is very excited to lead the introduction of a new British surgical robot, Versius (CMR) and as part of FRCC performed the very first robotic assisted radical nephrectomy in Europe using this device in March 2020.

Languages Spoken:

English

Medical School:

Charing Cross and Westminster Medical School, University of London

Residency:

Frimley Health Foundation Trust

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only